IFNG and bacterial infectious disease: LZD (20 mg/kg, 40 mg/kg, or 80 mg/kg q12h) pretreatment led to decreased IFN-γ and TNF-α production, decreased weight loss, and lower bacterial burdens at 24 h post bacterial infection in comparison with vehicle-treated controls.